NCT04874233View on ClinicalTrials.gov

Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

December 15, 2021

Conditions
NASH - Nonalcoholic Steatohepatitis
Interventions
DRUG

HU6

HU6 is active study drug

DRUG

Placebo

Non-active study drug N = 20

Trial Locations (1)

55114

Prism Clinical Research, Minneapolis

All Listed Sponsors
lead

Rivus Pharmaceuticals, Inc.

INDUSTRY